NP816330.RAEIUFw oEcOJqAPo0W LfX9feH8VYMT qKUJPXVCptIw
type: Nanopublication
has assertion: NP816330.RAEIUFw oEcOJqAPo0W LfX9feH8VYMT qKUJPXVCptIw130 assertion
has provenance: NP816330.RAEIUFw oEcOJqAPo0W LfX9feH8VYMT qKUJPXVCptIw130 provenance
has publication info: NP816330.RAEIUFw oEcOJqAPo0W LfX9feH8VYMT qKUJPXVCptIw130 publicationInfo
created: 2016-05-13T12:47:55+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP816330.RAEIUFw oEcOJqAPo0W LfX9feH8VYMT qKUJPXVCptIw130 assertion
type: Assertion
description: [Gene set enrichment analysis (GSEA) of the NF-kappaB target genes and 4394 additional gene sets covering various cellular pathways, biological processes and molecular functions have shown that translocation-positive MALT lymphomas are characterized by an enhanced expression of NF-kappaB target genes, particularly toll like receptor (TLR)6, chemokine, CC motif, receptor (CCR)2, cluster of differentiation (CD)69 and B-cell CLL/lymphoma (BCL)2, while translocation-negative cases were featured by active inflammatory and immune responses, such as interleukin-8, CD86, CD28 and inducible T-cell costimulator (ICOS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/20520640
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0